Trial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent Surgery
Prospective, Open-Label Clinical Study of Andexanet Alfa in Patients Receiving FXa (Activated Factor X) Inhibitor Who Require Urgent Surgery
Available Documents
Study Details
Medical Condition
Study Phase
Intervention Type
Product
DateMedical ConditionRequirement Information
Date
AgeDateParticipation Requirements
Inclusion Criteria
Exclusion CriteriaInclusion CriteriaProspective, open-label clinical trial to evaluate the efficacy and safety of andexanet alfa patients who require urgent surgery that have been anticoagulated with the FXa (activated factor X) inhibitors.
| Location | Status |
|---|---|
Location United States, Arizona Clinical Trial Site Phoenix, Arizona, United States, 85006 | Status Not Available |
Location United States, Arizona Clinical Trial Site Tucson, Arizona, United States, 85724 | Status Not Available |
Location United States, California Clinical Trial Site Long Beach, California, United States, 90806 | Status Not Available |
Location United States, California Clinical Trial Site Moreno Valley, California, United States, 92555 | Status Not Available |
Location United States, District of Columbia Clinical Trial Site Washington, District of Columbia, United States, 20037 | Status Not Available |
Location United States, Florida Clinical Trial Site Sarasota, Florida, United States, 34239 | Status Not Available |
Location United States, Florida Clinical Trial Site Tampa, Florida, United States, 33606 | Status Not Available |
Location United States, Iowa Clinical Trial Site Iowa City, Iowa, United States, 52242 | Status Not Available |
Location United States, Massachusetts Clinical Trial Site Boston, Massachusetts, United States, 02111 | Status Not Available |
Location United States, Massachusetts Clinical Trial Site Boston, Massachusetts, United States, 02114 | Status Not Available |
Location United States, New Jersey Clinical Trial Site Camden, New Jersey, United States, 08103 | Status Not Available |
Location United States, New York Clinical Trial Site Staten Island, New York, United States, 10305 | Status Not Available |
Location United States, North Carolina Clinical Trial Site Charlotte, North Carolina, United States, 28203 | Status Not Available |
Location United States, North Carolina Clinical Trial Site Durham, North Carolina, United States, 27710 | Status Not Available |
Location United States, Ohio Clinical Trial Site Columbus, Ohio, United States, 43210 | Status Not Available |
Location United States, Oklahoma Clinical Trial Site Tulsa, Oklahoma, United States, 74104 | Status Not Available |
Location United States, Oregon Clinical Trial Site Portland, Oregon, United States, 97239 | Status Not Available |
Location United States, Pennsylvania Clinical Trial Site Philadelphia, Pennsylvania, United States, 19104 | Status Not Available |
Location United States, Pennsylvania Clinical Trial Site Pittsburgh, Pennsylvania, United States, 15212 | Status Not Available |
Location United States, Pennsylvania Clinical Trial Site Pittsburgh, Pennsylvania, United States, 15213 | Status Not Available |
Location France Clinical Trial Site Nantes, France, 44093 | Status Not Available |
Location Japan Clinical Trial Site Kamakura, Japan, 247-8533 | Status Not Available |
Location Japan Clinical Trial Site Kawasaki, Japan, 216-8511 | Status Not Available |
Location Japan Clinical Trial Site Nagoya, Japan, 466-8650 | Status Not Available |
Location Japan Clinical Trial Site Sakai, Japan, 593-8304 | Status Not Available |
Location Japan Clinical Trial Site Sendai, Japan, 980-8574 | Status Not Available |
Location Japan Clinical Trial Site Tokyo, Japan, 113-8602 | Status Not Available |
